SCHEMBL15766180

SCHEMBL15766180

Cc1ccc(S(=O)(=O)[O-])cc1.Cc1ccc(S(=O)(=O)[O-])cc1.[Pt+2]

nearest known ligand 0.62

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.62
▸ CA1 P00915 4/20 0.56
▸ CA2 P00918 4/20 0.56
▸ CA12 O43570 2/20 0.56
▸ CA9 Q16790 2/20 0.56
▸ CA3 P07451 1/20 0.56
▸ CA6 P23280 1/20 0.56
▸ CA5A P35218 1/20 0.56
▸ CA7 P43166 1/20 0.56
▸ CA5B Q9Y2D0 1/20 0.56
▸ TLR9 Q9NR96 1/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 4/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ MMP1 P03956 1/20 0.50
▸ MMP2 P08253 1/20 0.50
▸ MMP9 P14780 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16034285 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8622705 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL6917577 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL8943269 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL17982097 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL18274782 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL346012 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL22615914 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL20583857 0.94 GAA (0.62) GAACA1CA2CA12CA9
SCHEMBL10917087 0.94 GAA (0.62) GAACA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104768962-B Leaving group is the platinum-like compounds of the malonate derivative containing amino or alkylamino 北京市丰硕维康技术开发有限责任公司 2017-04-05 — — CN claimed
CN-103649100-B Platinum compound with leaving group of succinic acid derivative containing amino or alkylamino, preparation method and application thereof 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN claimed
CN-103703011-B Platinum compounds with leaving group of hydroxy acid derivative containing amino or alkylamino, and preparation method and application thereof 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN claimed
EP-2740738-B1 PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASE, PREPARATION METHODS AND USES THEREOF BEIJING FSWELCOME TECH DEVELOPMENT CO LTD (CN) 2018-03-28 — — EP disclosed
CN-104768962-B Leaving group is the platinum-like compounds of the malonate derivative containing amino or alkylamino 北京市丰硕维康技术开发有限责任公司 2017-04-05 — — CN disclosed
EP-2759547-B1 PLATINUM COMPOUND HAVING AMINO- OR ALKYLAMINO-CONTAINING SUCCINIC ACID DERIVATIVES AS LEAVING GROUP, PREPARATION METHOD THEREFOR, AND USE THEREOF BEIJING FSWELCOME TECH DEV CO LTD (CN) 2017-01-18 — — EP disclosed
CN-103732601-B The one class treatment platinum compounds of cell proliferation disorders, its preparation method and application 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN disclosed
CN-103649100-B Platinum compound with leaving group of succinic acid derivative containing amino or alkylamino, preparation method and application thereof 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN disclosed
CN-103703011-B Platinum compounds with leaving group of hydroxy acid derivative containing amino or alkylamino, and preparation method and application thereof 北京市丰硕维康技术开发有限责任公司 2016-06-22 — — CN disclosed
EP-2924044-A1 PLATINUM COMPOUND OF MALONIC ACID DERIVATIVE HAVING LEAVING GROUP CONTAINING AMINO OR ALKYLAMINO BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT, CO., LTD (CN) 2015-09-30 — — EP disclosed
EP-2759547-A1 PLATINUM COMPOUND HAVING AMINO- OR ALKYLAMINO-CONTAINING SUCCINIC ACID DERIVATIVES AS LEAVING GROUP, PREPARATION METHOD THEREFOR, AND USE THEREOF Beijing Fswelcome Technology Development Co., Ltd (CN) 2014-07-30 — — EP disclosed
EP-2740738-A1 PLATINUM COMPOUNDS FOR TREATING CELL PROLIFERATIVE DISEASE, PREPARATION METHODS AND USES THEREOF Beijing FSwelcome Technology Development Co., Ltd. (CN) 2014-06-11 — — EP disclosed
CN-102993239-A Platinum compound of succinic acid derivative with leaving group containing amino or alkylamino CHEN XIAOPING 2013-03-27 — — CN disclosed
CN-102863474-A Platinum compounds for treating cell proliferative diseases and preparation method and application thereof CHEN XIAOPING 2013-01-09 — — CN disclosed
Send feedback